Sign In
Buy AFMD
$0.182
+0 (+0%)
At Close: Sep 16, 2025
Why Shares of Affimed Fell Thursday
04:01pm, Thursday, 17'th Nov 2022
The clinical-stage biotech focuses on immuno-oncology therapies.
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday
10:07am, Thursday, 17'th Nov 2022 Benzinga
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
InM
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
07:02pm, Wednesday, 16'th Nov 2022 Benzinga
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
InMed Pharmaceuticals Inc
Lowe's, Alcon And Some Other Big Stocks Moving Higher On Wednesday
03:57pm, Wednesday, 16'th Nov 2022 Benzinga
U.S. stocks traded lower, with the Nasdaq dropping more than 180 points on Wednesday. Here are some big stocks recording gains in today’s session.
Tiga Acquisition Corp. (NASDAQ: TINV) shares jumpe
Affimed N.V. (AFMD) Q3 2022 Earnings Call Transcript
06:44pm, Tuesday, 15'th Nov 2022
Affimed N.V. (NASDAQ:AFMD ) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET Company Participants Alex Fudukidis - Director of IR Adi Hoess - CEO Andreas Harstrick - Chief Medical Officer
Affimed N.V. (AFMD) Reports Q3 Loss, Tops Revenue Estimates
12:45pm, Tuesday, 15'th Nov 2022 Zacks Investment Research
Affimed N.V. (AFMD) delivered earnings and revenue surprises of 42.11% and 96.03%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Affimed Reports Third Quarter 2022 Financial Results and Highlights Recent Clinical and Corporate Progress
11:30am, Tuesday, 15'th Nov 2022 GlobeNewswire Inc.
HEIDELBERG, Germany, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back th
Affimed N.V. (AFMD) Reports Q3 Loss, Tops Revenue Estimates
09:02am, Tuesday, 15'th Nov 2022
Affimed N.V. (AFMD) delivered earnings and revenue surprises of 42.11% and 96.03%, respectively, for the quarter ended September 2022.
Alimera Sciences (ALIM) Reports Q3 Loss, Lags Revenue Estimates
01:55pm, Monday, 14'th Nov 2022 Zacks Investment Research
Alimera Sciences (ALIM) delivered earnings and revenue surprises of -102.70% and 12.83%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
HTG Molecular Diagnostics, Inc. (HTGM) Reports Q3 Loss, Misses Revenue Estimates
11:35pm, Thursday, 10'th Nov 2022 Zacks Investment Research
HTG Molecular Diagnostics, Inc. (HTGM) delivered earnings and revenue surprises of 21.15% and 44.40%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead f
Celldex Therapeutics (CLDX) Reports Q3 Loss, Tops Revenue Estimates
10:25pm, Wednesday, 09'th Nov 2022 Zacks Investment Research
Celldex (CLDX) delivered earnings and revenue surprises of 0% and 62.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Lags Revenue Estimates
01:25pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
Rhythm Pharmaceuticals, Inc. (RYTM) delivered earnings and revenue surprises of 21.78% and 20.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
10:00am, Tuesday, 08'th Nov 2022 Benzinga
Gainers
Digital World Acquisition Corp. (NASDAQ: DWAC) shares jumped 66.5% to settle at $29.10 on Monday amid recent reports suggesting Donald Trump could announce a 2024 presidential run this week.
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
05:46pm, Monday, 07'th Nov 2022 Benzinga
Gainers
Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.
Veru Inc. (NASDAQ: VERU) shares jumped 47% to $15.22 following publication of briefing documents ahead of the Nov.
Best Penny Stocks To Buy? 5 To Watch For November 2022
03:58pm, Monday, 07'th Nov 2022 PennyStocks
Penny stocks to watch this week.
The post Best Penny Stocks To Buy? 5 To Watch For November 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
